Agoracom Blog Home

Posts Tagged ‘tsx’

Hollister $HOLL.ca $HSTRF Provides Comment on Approval of Recreational Cannabis in Arizona $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 10:58 PM on Wednesday, November 4th, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • Company comments on the successful passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona
  • “Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024…” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona .

VANCOUVER, BC , Nov. 4, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co. ” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 80 dispensaries throughout Arizona provides comment on the successful passage of Proposition 207 – legalizing the cultivation, sale and consumption of recreational cannabis in the state of Arizona .

“Seeing recreational Cannabis legalized in the state is an encouraging sign and is hopefully another step toward federal legalization. It should lead to increased tax revenue and job creation. The recreational cannabis market in Arizona could be valued at up to US $760 million by 2024 1 , significantly expanding the total addressable market for Cannabis in the state. We look forward to making our product line available to both the medical and recreational end user.” Shared Jacob Cohen , Founder of Venom Extracts, Hollister’s 100% owned subsidiary based in Arizona .

Arizona Presence

Hollister , through its 100% owned subsidiary, Venom Extracts (” Venom “), is one of Arizona’spremier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products. With an experienced management team and unparalleled reputation for quality, Venom prides itself as a differentiated extraction company by producing legal cannabis products at a price point that allows retailers to generate higher profits. Focused on proprietary efficiencies, Venom is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company.

Website: www.venomextracts.com

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CAbirthplace of the “American Biker”.

Website www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

 
Source:  Marijuana Business Daily

 View original content to download multimedia: http://www.prnewswire.com/news-releases/hollister-provides-comment-on-approval-of-recreational-cannabis-in-arizona-301166780.html

SOURCE Hollister Biosciences Inc.

Arizona Voters Approve #Marijuana Legalization Ballot Measure SPONSOR: Hollister Biosciences $HOLL.ca $HSTRF $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 2:15 PM on Wednesday, November 4th, 2020

SPONSOR: Hollister Biosciences Inc. (HOLL:CSE) A vertically integrated Cannabis company with products in 280 California dispensaries, over 80 dispensaries throughout Arizona, joint ventures, licensing agreements and partnerships with Global brands. For the period beginning July 1 st , 2020 and ending September 30 th , 2020, Hollister generated record quarterly revenue of CDN$ 12.5 million and CDN$ 1.265 million in EBITDA. Learn More.

Arizona Voters Approve Marijuana Legalization Ballot Measure

  • A measure to legalize marijuana has been approved by Arizona voters, according to a projection by the Associated Press.
  • Advocates have paid close attention to the ballot initiative, as the state’s voters rejected a prior legal cannabis proposal in 2016.
  • Under the new legalization law, adults will be able to possess up to an ounce of marijuana at a time and cultivate up to six plants for personal use.

By Kyle Jaeger

AZ Proposition 207: Legalize Marijuana

CandidateVotesPercent
Yes done1,596,54859.85%
No1,071,25540.15%

2,667,803 votes counted. 81.64% – 98.11% in.

Results tracker sponsored by ETFMG | MJ.

“Until now, Arizona had imposed some of the strictest prohibition laws in the country; in some instances, the possession of even small amounts of marijuana was classified as a felony,” NORML Executive Director Erik Altieri said. “By rejecting this failed policy, no Arizonan going forward will be saddled with a criminal conviction for engaging in the personal possession or cultivation of cannabis, or face the lifelong stigma that comes with it.”

“Proposition 207 will disrupt the illicit market, end low-level marijuana arrests, create jobs and new revenue,” he added. “This result once again shows that marijuana legalization is not exclusively a ‘blue’ state issue, but an issue that is supported by a majority of all Americans—regardless of party politics.”

Polling was mixed heading into Election Day, with surveys consistently showing the proposal ahead, though by differing margins. In September, the Smart and Safe Arizona campaign shared an internal poll with Marijuana Moment that showed 57 percent of likely voters supported the  initiative, but a separate survey found just 46 percent in favor of the policy change. Additional polls last month showed the cannabis measure with a significant and growing lead.

The measure also contains several restorative justice provisions such as allowing individuals with prior marijuana convictions to petition the courts for expungements and establishing a social equity ownership program.

Cannabis sales will be taxed at 16 percent. Tax revenue will cover implementation costs and then be divided among funds for community colleges, infrastructure, a justice reinvestment and public services such as police and firefighters.

The Department of Health Services will be responsible for regulating the program and issuing cannabis business licenses. It will also be tasked with deciding on whether to expand the program to allow for delivery services.

The law technically goes into effect upon passage and after the voters are certified, which is expected to take place on November 30. After that point adults could legally use, possess and cultivate cannabis. However, regulators will still have to promulgate rules for overseeing the commercial industry. They can issue licenses starting in January 2021, and the first shops could be approved by February 1.

“Just four years after legalization was narrowly defeated, voters in Arizona turned out to send a clear message that they support marijuana legalization,” Steve Hawkins, executive director of the Marijuana Policy Project, said. “Following this victory, adults will no longer be treated as criminals for using a substance that is safer than alcohol and will be able to access it from safe and regulated businesses.”

Like other drug policy reform campaigns throughout the U.S., Smart and Safe Arizona faced significant obstacles qualifying its measure for the ballot amid the coronavirus pandemic.

At one point, activists asked the state Supreme Court to allow them to collect signatures electronically amid social distancing mandates, but that request was rejected.

Ultimately, the campaign submitted about 420,000 raw signatures. Secretary of State Katie Hobbs said that her office verified the petitions and determined that approximately 255,080 valid signatures were turned in. At least 237,645 were needed to qualify.

Opponents of the proposal, including Gov. Doug Ducey (R), released official voter guide arguments against the initiative in August. Supporters filed arguments as well, and all were circulated to voters in a pamphlet printed by the state.

Prohibitionists also released a series of attack ads that including misleading claims about what the measure would do and what has occurred in states that have already enacted cannabis legalization.

Source: https://www.marijuanamoment.net/arizona-voters-approve-marijuana-legalization-ballot-measure/

TGS Esports $TGS.ca Announces Signing of Definitive Agreement to Acquire Leading Competitive #Esports Platform, Pepper Esports $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 9:12 AM on Monday, November 2nd, 2020
TGS-square
  • Further to its news release of September 1 , 2020  it has entered into an amalgamation agreement with Pepper Esports Inc., a next generation competitive esports platform, and 1271801 B .C. Ltd., a wholly-owned subsidiary of the Company
  • Pursuant to which the Company will acquire all of the issued and outstanding shares of Pepper by way of a “three-cornered” amalgamation

VANCOUVER, BC , Nov. 2, 2020 – TGS Esports Inc. (” TGS ” or the ” Company “) (TSXV: TGS) is pleased to announce that, further to its news release of September 1 , 2020  it has entered into an amalgamation agreement (the ” Amalgamation Agreement “) with Pepper Esports Inc. (” Pepper “), a next generation competitive esports platform, and 1271801 B .C. Ltd. (” Subco “), a wholly-owned subsidiary of the Company, pursuant to which the Company will acquire all of the issued and outstanding shares of Pepper by way of a “three-cornered” amalgamation (the ” Acquisition “).  As part of the Acquisition, the Pepper executive team, Guy Halford-Thompson, Jackson Warren and Ben Hoffman, who have  a decade of combined experience in growing early-stage companies in the public markets, will join the TGS executive team.

The Pepper platform offers an advanced suite of tools for league operators, tournament operators, and venue owners to effortlessly set up and manage esports communities and run world-class events. These include key innovations, such as automatic game scoring technology, that uses Pepper’s patent pending AI engine and saves event organizers hundreds of hours of setup time, live leaderboards which vastly improve player and spectator experiences, a universal ranking system that ranks players across all competitive games, and more.

Transaction Highlights

  • Develop New Revenue Streams – the Acquisition is expected to provide TGS with diverse new online revenue streams that include data monetization, payment processing and recurring subscription revenue.
  • Expanded Consumer and Business Base – the combined company will have the ability to acquire users from all over the globe through tournaments of any kind.
  • Highly Accomplished and Experienced Team – the completion of the Acquisition will add a team with over a decade of combined experience in growing early-stage companies in the public markets.
  • Technology Platform – The Acquisition adds a technology platform to TGS, which is scalable, global, and with defensible IP.

“The online gaming market has exploded in 2020, with recent stats showing an estimated 2.7 billion gamers across the globe ( https://www.statista.com/statistics/293304/number-video-gamers/ ). The combination of TGS’ event expertise and Pepper’s leading platform allows us to reach all gamers, regardless of location.” said Spiro Khouri , CEO of TGS. “With this acquisition, we are in a unique position to offer an all encompassing esports experience to any tournament organizer, gamer, or company looking to market to this growing demographic.”

“Working closely with the TGS team, we are already seeing accelerated interest in the Pepper platform. Being able to offer a full suite of services from integrated streaming to full event management sets us apart from other platforms.” said Guy Halford-Thompson , CEO of Pepper. “Now the definitive agreement is in place we can start to execute our plans to scale and grow our platform.”

Summary of Acquisition

Pursuant to the Amalgamation Agreement, on closing of the Acquisition (” Closing “), the Company will issue to each holder (each, a ” Pepper Shareholder “) of common shares of Pepper (each a ” Pepper Share “) three (3) common shares of TGS (each a ” TGS Share “, and such TGS Shares issued as consideration for the Acquisition, the ” Consideration Shares “) for each one (1) Pepper Share (the ” Exchange Ratio “) held by such Pepper Shareholder at a deemed price of $0.14 per Consideration Share for aggregate deemed consideration of approximately $6,073,993. The Consideration Shares will be subject to a contractual lock-up, with 20% of the Consideration Shares being released on Closing and a further 20% being released every six months thereafter. The Consideration Shares may be subject to an additional escrow period as required by the TSX Venture Exchange (the ” TSXV “).

Each outstanding security of Pepper that is convertible or exchangeable for Pepper Shares will be exchanged for corresponding securities that are convertible or exchangeable for TGS Shares on substantially the same economic conditions.

The Acquisition is subject certain conditions including: (i) the receipt of all necessary approvals from the respective shareholders and boards of directors of each of Pepper, the Company and Subco, (ii) the approval of the TSXV) (iii) Pepper shall not have received notices of dissent to the Acquisition from Shareholders holdings more than 5% of the issued and outstanding Pepper Shares, (iv) the employment agreements of Guy Halford-Thompson , Dallas Benjamin Hoffman and Jackson Warren shall have been assumed by the Company (v) there having been no material adverse effect occurring with respect to Pepper or the Company; (vi) Pepper shall have received the consent from the holders of options or warrants to purchase Pepper Shares to the exchange of such securities for equivalent securities to purchase TGS Shares, and (vii) other closing conditions customary for transactions of this nature.

The Acquisition is not a Non Arm’s Length Party transaction. A finder’s fee is expected to be payable in connection with the Acquisition, subject to the approval of the TSXV, and further details will be provided once available.

Directors and Officers

On Closing, it is expected that Guy Halford-Thompson will be appointed as President and a director of the Company, and Dallas Benjamin Hoffman and Jackson Warren will be appointed as Chief Technology Officer and Chief Product Officer, respectively.

Guy and Jackson have worked together since 2016, during which they have had five successful exits, three via acquisition (QuickBitcoin, Bitcoiniacs and Xapcash) and two via public listings (TSXV:BTL, TSXV:DASH). Guy is also a founder and board member of Eli Technologies and Minehub, both of which are due to list in late 2020.

Over the last 4 years, Guy and Jackson have raised over $35m in funding and delivered $500m in investor returns. BTL was founded by Guy, Jackson and Guy’s brother in 2015 and was joined by Ben in early 2017. It delivered early investors significant returns by the time Guy and Jackson exited the company in 2018.

Guy, Jackson and Ben have a strong track record of delivering investor value, and believe they have discovered a truly unique and rare opportunity with Pepper.

Haywood Securities Inc. has acted as a financial advisor to Pepper in connection with the Acquisition. The Company and Pepper deal at arm’s length with each other, and the Acquisition is not expected to result in a change of control of the Company.  A finder’s fee in an amount to be determined at a later time may be payable in connection with the Acquisition, subject to compliance with applicable securities laws and the approval of the TSXV.

About Pepper Esports Inc.

Pepper is a leading esports platform provider that offers an advanced platform to create and manage communities of players, organizers, spectators and sponsors, all in one place.  By working closely with event organizers and live venue operators over the last two years, Pepper has developed a suite of advanced tools to manage esports communities, run world class esports and operate physical gaming venues.

Pepper’s key technologies include its patent pending AI engine, which automatically captures game data to create a tournament experience that extends beyond live gameplay and includes highly demanded features such as global leaderboards, player profiles and statistics, new tournament discovery and digital wallets.

About TGS Esports Inc.

TGS Esports Inc. is an esports organization focused on providing an unparalleled esports experience through its expertise in online and in-person event management, broadcast production, and Pepper Esports tournament software. TGS is the owner of Canada’s first dedicated esports arena, The Gaming Stadium, located in Richmond, British Columbia , which opened in June 2019 . The Gaming Stadium hosts regular online tournaments as well as provides high quality broadcast production for any event. For more information, visit www.thegamingstadium.com .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

On behalf of the Board of Directors

Spiro Khouri

Spiro Khouri , CEO
TGS Esports Inc.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future, including with respect to: the completion of the Acquisition and the acceptance of the Acquisition and terms thereof by the TSXV, the expected directors and officers of the Company following Closing, the expected benefits of the Acquisition to the Company. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company. The risks include the following: the unknown magnitude and duration of the effects of the COVID-19 pandemic and other risks that are customary to transactions of this nature. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them.

This press release is not an offer of the securities for sale in the United States . The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an exemption from registration. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful.

SOURCE TGS Esports Inc

Else Nutrition $BABY.ca $BABYF to Present at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:26 AM on Monday, November 2nd, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that it will be participating at this year’s NASPGHAN (North American Society for Pediatric Gastroenterology, Hepatology and Nutrition), November 1 st to 7 th
  • Else’s virtual booth will enable live conversations with small groups, and one-on-one educational sessions, among the nearly 2,600 anticipated attendees
  • The forum will place Else Nutrition alongside some of the leading blue-chip nutrition companies, including Pfizer, Abbott Laboratories, Nestle and Danone

VANCOUVER, BC , Nov. 2, 2020  – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (” Else ” or the ” Company “), a developer of plant-based alternatives to dairy-based baby nutrition, is pleased to announce that it will be participating at this year’s NASPGHAN (North American Society for Pediatric Gastroenterology, Hepatology and Nutrition), November 1 st to 7 th .  Else’s virtual booth will enable live conversations with small groups, and one-on-one educational sessions, among the nearly 2,600 anticipated attendees. The forum will place Else Nutrition alongside some of the leading blue-chip nutrition companies, including Pfizer, Abbott Laboratories, Nestle and Danone.

“We are working diligently to build awareness of our products with America’s top pediatricians and medical experts” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else. “We want them to form their own unbiased opinion of ELSE’s health benefits for babies and we are excited to introduce and promote our plant-based product to this professional crowd at NASPGHAN .  Educating the medical community is a major pillar of our marketing strategy,” she added.

This year’s annual summit is virtual due to COVID-19.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for sale on Else’s e-store at elsenutrition.com , and on Amazon.com.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean, plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition organizations. Many of Else advisory board  members held executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in prominent roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

VIDEO – Primo Discusses MOU For Exclusive Rights to Sell Rapid COVID-19 Test Kits In Canada + Upcoming Spinout of Marianna Naturals

Posted by AGORACOM-JC at 5:52 PM on Friday, October 30th, 2020

Welcome to be on the press release a production of AGORACOM in which we speak to small cap management about their company with us today happy to have him back Richard Cedric is managing director at Primo Nutraceuticals trades on the CSE under the stock symbol P. R. M. O. and 4 friends the US under B. U. G. V. F. now for those who knew the story there’s been a lot going on a lot of re position going on at the company our basic couple these are helping their their their funding the rapid growth of production process retail and branding of cannabis and non cannabis natural health products being important for this off for this purpose that they’ve invested several brands they’re pursued partnerships with retailer distribution companies in Canada the U. S. they got a spin out that’s common they’ve got there M. D.E. L. that’s our medical device License and that’s important because the press release the may possibly talk about today is a Primo signs and amble you for the exclusive rights to sell the rapid Covid 19 test kits in Canada. These are the colloidal gold method Richard welcome back man. Hey thanks for having me great intro right up. Well look Hey that look above the first thing people said people think about when they see something like this is saying all now somebody else trying to get to the Covid19 space but this rapid test it is currently registered with the with the FDA and it’s got its C. E. declaration with with the European community as it are and as has already been operating in China so before we get the details of the deal what is it what do these mean exactly and why is that important to stopping the credibility of you guys bring in have the exclusive rights to this test well the first thing that that we did that brings credibility to us is establishing and getting our medical devices license and our procurement number from health Canada so we could go ahead and and actually import and and submit products like this to help Canada for approval so that’s the first step I mean a lot of companies like Hey I I got this test yet we’re going to be selling it you’re the U. S. with the F. B. through the FDA approval and so forth we’re not we’re not even talking about that we have to be approved first by getting a medical devices license you for health Canada will even look at us so that medical devices license allows us to import and shipped out gloves and N95 masks gloves and testing kits and  it’s only I can go sign up for this.  Articulate behind license first and what allowed us to get the medical devices license is because we had our natural health product number from health Canada which was issued before the medical devices license so there was a trail here leading up to this and it had everything to do with capitalizing on the medical devices license industry given this you know sadly to say this pandemic that is is happening but this is our way of trying to help out in and bring these testing kits to fruition so this particular testing kit was used in during the largest outbreak in China back in February so this test kit has been used by the CDC. It was basically donated to hospitals the CDC distributed in the mostly severe we infected areas and it already comes with clinical trials so the. Health Canada is gonna be requesting any company that is submitting a test kit to have clinical trials and there’s probably about 10 to 15 maybe 20 of them who have submitted a similar test kit or a test kit but not like this because these clinical trials have already been completed almost a year ago where other companies submit application are in the midst of clinical trials so we feel that we’re we’re gonna be out pushed to the top of the line only because clinical trials of already been completed S. all I can is the Guinea pig because it’s sold in other countries already right now once you name those often let’s talk about what that means yeah at present Iran Italy and the United States and other red zone our countries are already using it and obviously coming out of China who seem to be the leader in providing a direction on how to how to combat this cold it will be 19 pandemic is is relevant other companies are actually in the U. S. you know I’ve come up with the product they develop it in the U. S. and now they’re in clinical trial phase right so again we’re idea there behind you technically because this product already has a clinical trials ready to go that’s right that’s right clinical trials of. So part of this is you need to get product license approved by health Canada at that point you’ll have official dealer distribution distributor status with with your Chinese partner you got that M. D. L. we know that so that put you like you said probably near the top do you have an ETA for how long it might take to get this approved by health Canada and and W. W. get even what’s the probability is 5050 is a very high degree of probability what do you guys seeing as investors in the world don’t know you know if these things are getting approved and or what right. Okay so from what we’ve been made aware of is that there’s been one test kit approved so far in Canada and the reason why we and we should be hearing back anywhere from 15 to 25 days as to if we’ve been approved and the reason why we feel that we would be ahead of the line is given our clinical trials right and with that we were do you attain those objectives of of having clinical trials it was a win would you guys submit when you guys submit to health Canada last week it was a couple days after we announce the PR all right so you talk about last. Right. Well it’s October 23 so you talk and let’s say your worst case there are 25 days talk about November 20 give or take time yeah in worst case yeah and mid November we should know if we have or haven’t gotten it I really don’t see why we wouldn’t get it if we are past clinical trial phase but you never know and it’s a high I would say maybe 90-99 percent believe that we might get it because that’s what I’m being told what’s slowing down these companies is that they don’t have their clinical trials completed right right and you guys have got a dispute in the field the target it reduce the rand in Italy in the US over pretty big hot zone so I gotta figure you know health Canada have a problem if they’re already being used there Richard let’s assume you guys got it okay first second half the battle is getting a license like this are you know getting approval getting a partnership  you guys are are teaming up with this you are with with the company is great Neo-Nostics. You get it it’s already go how the other half the battle is how do you make money from it so what I mean by that is if you can answer what’s the marketing plan how do you get this out there with the price points you know what the numbers look like what because you guys I’m sure before you came down this path I’ve probably run some numbers maybe you can give us an idea of where you guys looking at. Okay so numbers wise we have out like like I said we’d be the same the. Product license and distribute their official dealer in Canada there’s 500000 units put aside for us the numbers are pretty big if we’re talking about $50 or 25 to $50 per her up unit you know we’re we’re in the $25000000 range right so around there and I mean the margins are yet to be discovered but gross income that we’d be sharing with Neo-Nostics is north the $20000000 range or all of them all right. Are you trying to be more B. 2 B. are you going to have this you’re going to go up. No that’s. Both. I think right away what we’ll do is contact the distributors that are already you know in that in that framework as well as bring on people to do the B2 B. I mean we’ve got we’ve got actually an ad on indeed for these these types of positions to be filled and we’re doing a financing at $0.10 for $5M to basically be able to follow through with getting these products overboard over over to our shores and then distributed effectively so we’ll be doing a combination of both will let the distributors know that we’ve got this product for sale as well as lead but the large institutions like airports schools and government German agents know that we’ve got this test kit available and approved by health Canada. The research have you start to reach out to them just to kind of you know just in case yeah I I actually in the approval process there was a a section there that basically would let all the German agents know that we’ve been about this particular product has been approved by health Canada all right all right so you know yet what’s the feedback and kind of seeing I’m curious you know are people saying Hey guys once you get this will will definitely want to be taken orders or would use would you stand out we’re we’re talking specifically to schools as well as hospitals and we’re basically getting quoted up 50 thought looking for quotes are 50000 products at a time that’s so far been our largest request for proposal was 50000 units so 10 percent of what are what are actual inventory would be so I think this thing is going to fly off the shelves like one mining company alone which would be interested in a 50000 units because these units are disposable right it’s similar to a pregnancy test your your right **** on the finger draws a little bit of blood and within a couple of minutes you’re you’re aware of what what do you have it or not and there’s a video on the link to the press release of your data shows you how the product works and that’s available for everybody to see it all yeah it was the second to last press release. . But that probably start it went in to add George’s that further back anticipating this we hired a gentleman by the name of Dan Duquette who’s an ex MLB executive and entered the PPE space are a little bit sooner than we did but given his contacts with like you know individuals that are in government positions you know he’s going to be he’s an example of the kind of people that were looking to join the team to help get rid of this casket worker remote the Tuscan. All right so let’s sit back on that that’s a great overview and let’s wait for mid November to see where hopefully you get that first as a Canadian I hope you get that because a citizen would be great to know look I’ve got family I’ve got friends and yelled in in Ontario their backlog 2 or 3 weeks almost doesn’t matter if you get if you get a result now if it’s if you find out you’re positive the but the tells of 2 weeks ago you price front the 0people anyways so right to have it be great to know that these these will be available yeah so and then secondly as a shareholder absolutely right B. you know because so let’s wait till mid November I have our fingers crossed that that happens for both citizens and for shareholders all the other peace news I want to talk about is a pure primo shareholder today or rethinking become approval shareholder you’re going to get our share in Marianna you know what we talk about that and tell us where it’s at yeah for sure so back on April 29 we signed a definitive agreement to help assist beauty kitchen really is the company going to be course public but eventually representing a beauty kitchen so yeah you know we started out on April 29 and at the same time Joel who’s one of our directors was the is the CEO of Marianna he’s been working diligently and so free up pushing this through so it was issued we put out a press release actually yesterday that it retained a transfer agent and has secured its number so that shows that we are very close to this thing trading I think it’ll be trading mid to end of January but you know there’s no reason to wait so yeah basically the ratio would be for every share that you own in primo you’ll get a free share of Mariana and that’s not and that’s saying something because people got a pretty tight share structure right. Yeah we’ve only got that right now we’ve got 10.5m shares outstanding up until January where we will have a total of about 23 to call the 24000000 shares out by mid January so yeah and the mean time you know if we do get this this approval and with only 20M shares outstanding and 6M in the float I see companies with those types of ratios get into the tent you know multiple up 5 to 10 points right so this is at no time to wait on when you’re thinking about getting into the stock that’s only got 10000000 shares in this trading at $0.12 yeah that that yeah that’s fantastic and tells a little bit about the about the business that’s going to be underlying you know the Marianna. We got the bill the underlying business of Marianna to get his beauty kitchen so beauty kitchen is a business that has been around since 2014 she was basically became popular by well I live streaming videos where she was taking products that you find in your  kitchen cabinet and make up you know any type of cosmetics lipsticks and so forth beauty products in general and it took off so she’s developed a line of a product’s Marianna core and beauty kitchen and Marianna’s objective is to add the CBD component to our beauty kitchen’s product line but you know that doesn’t stop the company from possibly doing a a a you know a small takeover of beauty kitchen’s existing revenue shares so that’s something to look at so it’s really you know when you talk about Marianna natural court it’s the subsidiary of beauty kitchen and beauty kitchen is all over the internet for products and so forth so we’ll be all. This is that’s brought into the public company hello hi or the network AV I know I believe about it over a period of time Marianna could possibly become beauty kitchen or vice versa beauty kitchen will end up being the buckle of with depending on how much what percentage is required but similar to what we did with the with thrive wellness 39 percent you know interest is probably something that Marianna might as well might do as well in beauty kitchen. Yeah at some point be great what we do is maybe after November 15 is you know just to corporate data relays out each 1 of these because you guys are you know you kind of funding these companies are investing in summer brand partnerships would be greater because you know the the after after primo went through some good restructuring it’s really starting to set itself up for a winning it all winning structure for 2021 would be great if we agree with that I mean that was the reason for the name change so we can capitalize on not only the THC and CBD market but the natural health market and it just opens up a wide variety of options that we have and even prior to. This acquisition of the up or M. O. U. we announced a cut to press releases to do with the mushroom market you’ll see that David no shot is an individual that has was granted the ability to do research on Gino typing it Kimmel typing of CBD products so now he’s going to come on board with us and do the same type of of research for the mushroom space and hopefully you know we could be one of the companies that gets the second micro dosing license so because we’re a nutraceutical company it’s allowed us to do that and our short term objective. Is is the seat is the PP space and our long term objective is you know sticking to the natural nutraceutical space and you know developing the this I. P. through the psilocybin with David no shot as well as you know with a lot of these marijuana companies you can get get into a project on pennies on the dollar but he’s on the dollar and we’re looking at farms right now which can encompass art sheet C. B. D. and continue on with the P. P. as a nutraceutical company right well great that you got an issue for both the short term like this M. O. U. for the rights of the covert 19 rapid test EDM term yeah like Marianna and and the long term through what you’re doing with the R&D. and the silence of bins and and and the psychedelic side I think that’s a great combination for a small cap company well you know what another thing is to it was pretty critical changing the name to primo and becoming a nutraceutical company because we’re getting contact from trivago’s in the US wanted to piggy back in doing similar what we are doing with Marianna so once we get Marianna through the goal line we’re gonna be doing a lot more spin outs because we was successfully done one and we know what to do because you and I both know lot of companies announced they’re doing a spin out and a lot of them don’t even come through so we want to get this one through the finish line show that we’re a company that actually does what they say that they’re going to do and and and continue on with identifying you know nutraceutical brands that can fall under the cream on on Broadway and primo is a terrific branding name when you consider media. Yes because what do you ask what for when you’re looking for a a a quality product you ask if it’s primo give me the primo stuff baby primo stuff baby now it’s great to know I looked at how to get to know that you got that one as a shareholder that I am sure older people are watching that you’re going to get a one for a one for one spin out that’s just almost too good to give half right we don’t and and and again we just announced that they’ve secured the transfer agent because they received . Nothing says that we are anticipating trading our common shares swiftly in the future than that so yeah right yeah absolutely I mean still has to happen look for the covert 19 does still got to get the health Canada for the spin out that’s going to happen but the fact that they’re both on track and they’re both locked up. On the menu you’re not just taking shots in the dark here which is great I’ll I’ll be honest with you Marriott Corp would be trading by now. But we’ve been you know the rollback caught you know because the delay and all we’re waiting on is basically calling our AGM which is we’re weeks away from that once that happens you know we’re we’re basically at the goal line with the spin out. Set number great 2021 man. 2021 great see the you guys came through some turbulence earlier in the year and now you know you’re really getting the ship on the right direction and can’t wait to have you back Richard. Yeah thanks George appreciate your guys support and again remember we’re out we’re doing a financing here $0.10 so if any of your people are interested I’m sure they can contact us on the website or Regis any by email got a great story I’m assuming you’re in the private placement also means that you’re going to get you know that and that share in Marianna right off get looks like you’re actually securing your your share Marianna because because yeah you’re you’re participating in the P. P. but that is a guaranteed if you did you participate in the PP you secure your position America.  You can watch and or if you listen by podcast to Richard Cindric managing director primo nutraceuticals trade on the CSE under the stock symbol P. R. M.O a fantastic name it’s the Primo name and look if you want more information to get kind of caught up with the story because you’re probably discovery again the company had to go through some restructuring but did a great job of pivoting you know seeing it more problems in the market pivoting out and and really doing some great things now as you heard from Richard self get to court get too bored calm start your research thank god over the primo site do more research there hope you discovered your next great small cap companies thanks for joining us everyone have a fantastic day see you next time.

Else Nutrition $BABY.ca $BABYF Plant-Based Infant Foods Launch in Over 380 US Retail Locations $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 4:09 PM on Friday, October 30th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Else Nutrition Holdings which develops plant-based alternatives to dairy milk-based baby foods, announces the early availability of its innovative products in US retail stores. The company expects to begin first retail sales through KeHE distributors in the western and southern regions of the United States as early as the end of November 2020.

Else began trading on the Toronto exchange last June and saw huge stock market interest upon its launch, being touted as hot stock to watch, in its plans to disrupt dairy nutrition for infants. Else says thats its products are the first viable choice other than dairy and soy in in this category for over 120 years.

Up to four regional customers and one national key account, for a total of 380 shops, will be served before the start of the Christmas season, following the recent successful launch of its plant-based baby food products through its online store and via Amazon. Else is now working diligently through a network of food brokers and KeHE sales partners to acquire strategic customers in the stationary trade in various key regions of the USA.

“The lively interest in our product makes us very optimistic. Parents and families have long been waiting for a plant-based alternative to milk-based baby food. Soon, parents across the United States will be able to buy our product in a shop near them and also order it through online retailing,” said Hamutal Yitzhak, CEO and founding member of Else.

Source: https://vegconomist.com/companies-and-portraits/else-nutrition-plant-based-infant-nutrition-launches-in-over-380-us-retail-locations/

$VALE completes first sale of iron ore using #blockchain technology with Nanjing Iron & Steel – SPONSOR: Blockchain Foundry $BCFN.ca $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 3:33 PM on Friday, October 30th, 2020

SPONSOR POST:

http://blog.agoracom.com/wp-content/uploads/2020/10/blockchain-foundry-square.png

BCFN:CSE

  • A leading North American blockchain development firm
  • 2020 H1 Revenue Of ~$900,000
    • 187% Year Over Year Growth
    • Positive Net Income
  • Self sustaining consulting practice with growing pipeline and potential upside from product development and commercialization
  • Partnered with Binance, the largest digital asset trading platform in the world, to leverage the Syscoin platform.
  • A Blockchain company with Real Products, Real Customers, Real Revenues and Real Income
  • Blockchain Foundry is a “Blockchain 2.0” company that has survived and will thrive  

Hub On AGORACOM / Corporate Profile

Vale completes first sale of iron ore using blockchain technology with Nanjing Iron & Steel

  • Vale, one of the world’s largest mining companies, completed its first sale of iron ore using blockchain technology with Nanjing Iron & Steel Group International Trade Co., Ltd., a subsidiary of Nanjing Iron and Steel Co., Ltd. (NISCO) for a cargo of 176,000 tons of Brazilian Blend Fines (BRBF) from Teluk Rubiah Maritime Terminal, in Malaysia, to China.
  • Vale said this transaction is aligned with its strategy of becoming a more innovative and customer-centered company through greater integration with clients and partnering for the development of new solutions.

Vale also called it an important milestone towards the digitalization of the sales and trade process, bringing innovation to the traditional paper-intensive trade transactions and offering a better service to the clients as well as predictability in the steel value chain.

The Letter of Credit (LC) was issued through the Contour blockchain platform while the shipping documents and the electronic Bill of Lading were handled via essDOCS’ CargoDocs solution—with all actions carried out through a single, interfaced platform consolidated in Contour. The transaction also had the support from DBS Bank Ltd and Standard Chartered Bank Malaysia Berhad.

The integrated transaction enabled end-to-end security and transparency with real time visibility of the documentation to all stakeholders, drastically reducing the amount of emails and paperwork exchanged among the parties and providing enhanced user experience through access to a single solution to execute the trade.

Source: https://www.greencarcongress.com/2020/10/20201030-valeblockchain.html

Defense Market Size Anticipated To Exceed USD 10.5 Billion By 2023 – SPONSOR: KWESST Micro Systems $KWE.ca $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 5:28 PM on Thursday, October 29th, 2020

SPONSOR POST:

WHY KWESST? HERE’S SOME GREAT REASONS

1.   KWESST is a leader in defensive technologies that increase the capabilities of soldiers, including
those of NATO and its allies

2.  These technologies make a critical difference to soldier safety and effectiveness

3.  The Leadership team experience spans decades and hundreds of millions of dollars in military and homeland security contracts.

4.  KWESST develops next-generation systems for forces around the world, with a particular focus on special forces among NATO countries and their allies.

Image-1

5.  KWESST partners with globally recognized equipment manufacturers to integrate its systems into
their solutions to create high value-add products for global customers.

Image-2

KWESST Upgraded to SAMSUNG “USA Partner” Status

  • Announced the elevation of its affiliation with SAMSUNG Electronics America Inc. to “USA Partner” status
  • KWESST will be employing the SAMSUNG S20TE tactical smart phone in the production version of the Company’s Tactical Awareness and Situational Control System (TASCS) and for its Integrated Fires Module (IFM) for networked targeting on soldiers’ weapons
  • SAMSUNG S20TE device, also known as the Galaxy S20 Tactical Edition, is the latest mission-ready military smartphone built and proven by operators in special operations for rapid information capture, sharing and analysis in diverse operating environments

6.  KWESST provides small cap investors with a rare opportunity to invest in a high-growth, technology driven, global defence company with:

  • Tier-1 Customers
  • Global Customers
  • Proprietary Technologies
  • Diversified Products
  • Globally Renowned Executive Team With Massive Successful Track Records

—————–

Defense Market Size Anticipated To Exceed USD 10.5 Billion By 2023

Defense market size was valued around USD 6 billion in 2014 and is anticipated to exceed USD 10.5 billion by 2023, growing at a CAGR of over 6.1% from 2016 to 2023. The growth can be mainly attributed to increasing technological innovation and advancement. The technological improvements are expected to improvise the military power and thus resulting in making it stronger. Various nations are now concentrating on developing the protection systems for themselves as well as to trade with other militaries.

Proliferating security concerns among various nations and rising government spending in research and development activities is likely to propel the industry growth. Nations assessment of its security is mainly responsible for shaping its security system. As the country’s economy grows its security spending also increases. Nations are now retooling their fighting abilities towards more affordable and updated technology.

Countries such as China, Israel and Russia defense market see significant spending in improvising their resistance systems. As of 2015, U.S spends around 54% of its fiscal budget for military utilities and accounted for 37% of the overall industry share. It spends as much as USD 610 billion and ranks first in case of defense expenditure across the globe. Japan, China, United Kingdom, Russia, Germany, South Korea, France, Saudi Arabia and India collectively valued for USD 601 billion in 2015.

The global defense market is estimated to face two major challenges over the forecast period namely, profitability growth and cost cutting to maintain financial performance. In order to tackle these conditions several counties namely India is now focusing on defense foreign investments and technology platforms for increasing production operations in the country. As of 2015, The Ministry of Commerce and Industry (MC&I) has modified its FDI limit from 26% to 49% in order to improve country’s own security system. Moreover, declining resistance budgets accompanied by rising development costs is expected to hamper defense market growth from 2016 to 2023.

In addition, countries namely UAE, Saudi Arabia, India, South Korea, Japan, China and Russia exhibit potential growth prospects owing to threat from other countries. Defense companies are expected to witness huge growth opportunities owing to increasing investment in next generation ISR, unmanned combat land and sea vehicles, cognition & data analytics as well as improved precision strike with the assistance of non kinetic weapons. The defense market can be segmented on the basis of platform which includes airborne, naval and land based.

U.S. MDA (Missile Defense Agency) and Raytheon are jointly working on development of MOKV (Multi-Object Kill Vehicle) concept. These are specialized equipments that are likely to steer itself to the target and destroy the objects in space. In addition, India has test fired its AAD (advanced air defense) interceptor missile developed by DRDO (Defense Research and Development Organisation). It is a single-stage, anti-ballistic missile designed to suspend incoming missiles from an altitude of 30 kms. When integrated with Prithvi air defense missile, the experiment might result in two-tier ballistic missile defense system which is developed to intercept any threat from an altitude of 5000 kms.

Key industry participants in defense market share include Boeing, EADS/Airbus, United Technologies, Raytheon, Northrop Grumman and General Atomics Aeronautical Systems, ABG Shipyard Limited (ABG), Adcom Military Industries, Bharat Dynamics Limited, Brazilian Company Avionics Services, CADES Engineering Technologies Ltd, Cassidian Cyber Security, EBV Explosives Environmental Company, Direction des Constructions Navales Services (DCNS), BAE Systems Information and Electronic Systems Integration Inc. (US), EUREST Raytheon Support Services , European Advanced Technology S.A., Hispano-Suiza, HCL Aerospace & Defense and Advance Tech Control Pvt Ltd among others.

Source: https://www.gminsights.com/industry-analysis/defense-market

#Veganuary Celebrates 1 Million Participants As Plant-Based Diet Goes Mainstream – SPONSOR: PlantX Life $VEGA.ca $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 4:20 PM on Thursday, October 29th, 2020

SPONSOR: PlantX Life Inc. (VEGA:CSE) – The Digital Face of The Plant – Based Community. The company is aiming to be the most trusted online destination for the plant-based community and those interested in living a plant-based lifestyle which includes the following;

  • Plant Based Meal Delivery – 20 unique 100% plant based meals for home delivery
  • 20,000 items including snacks, drinks and even chocolate
  • Plant Based …. PLANTS (It’s A BIG Business!)
  • Plant Based Pet foods
  • Plant Based Restaurant Locator
PlantX | LinkedIn

—————–

Veganuary Celebrates 1 Million Participant As Plant-Based Diet Goes Mainstream

  • Veganuary, the U.K.-based campaign encouraging people to eat vegan for the month of January, has just hit the 1 million supporter mark since its inception in 2014
  • The achievement is testament to the growing plant-based trend, especially in the wake of the coronavirus pandemic, which has sent consumers all over the world looking for healthier, more sustainable and safer alternatives to animal foods.

By Sally Ho

Veganuary, the U.K.-based campaign encouraging people to eat vegan for the month of January, has just hit the 1 million supporter mark since its inception in 2014. The achievement is testament to the growing plant-based trend, especially in the wake of the coronavirus pandemic, which has sent consumers all over the world looking for healthier, more sustainable and safer alternatives to animal foods. 

Announced on Monday (October 26), Veganuary has welcomed its one millionth participant joining the movement to try veganism for 31 days. Since the campaign first began in 2014, it has attracted the support of big names, including television presenter Jasmine Harman, actor Peter Egan and renowned wildlife presenter Chris Packham

Harman, who took part in the first-ever Veganuary six years ago, broadcasted a video message congratulating the charity on the milestone. “I feel very proud and very privileged to have been with Veganuary from the start and to be one of their ambassadors,” she said. 

In its first year, Veganuary attracted just 3,300 supporters, but it quickly rose to fame as plant-based foods have come to garner greater spotlight in recent years as consumers begin to couple the environmental footprint and health impact of their food choices. The one million total includes the record-breaking 400,000 participants that joined the movement this year, a jump from the 250,000 figure in 2019, and 170,000 in 2018.

One million official Veganuary participants in just seven years is a huge achievement, but the momentum behind the plant-based revolution will see us hit two million in no time. Matthew Glover, Co-Founder & Chair of Veganuary

The real figure is likely to be much higher than one million, given that people around the world are believed to have taken part in the event without signing the official pledge online. A significant number have also continued their plant-based diet after the month of January. According to research conducted by data insights firm Kantar, the actual number of people who have participated without officially signing up is around ten times higher. 

Commenting on the milestone, Matthew Glover, the co-founder and chair of the charity, said: “Now Veganuary is a bigger feature in the retail calendar than Christmas, reflecting the ever-increasing number of people choosing plant-based food.” 

“One million official Veganuary participants in just seven years is a huge achievement, but the momentum behind the plant-based revolution will see us hit two million in no time.”

Signatories to the pledge have come from every single country in the world apart from North Korea, Vatican City and Eswatini. In 2020, the most growth in supporters was recorded in Latin America, followed by India – two major markets where plant-based foods have experienced a surge in demand.

All over the world, consumers have been shifting towards plant-based foods more than ever before, particularly in the wake of the pandemic, which has exposed the vulnerabilities and dangers of the animal meat supply chain. With the trend firmly in the mainstream, food giants have been scrambling to tap into the market – the latest research shows that almost 40% of the biggest food manufacturers and retailers in the world now have dedicated plant-based teams

Plant-based meat makers have also celebrated a big win in Europe just last week, when EU leaders prevented a proposal that would ban plant-based alternatives from using “meaty” terms like sausages or burgers on their labels.

Source: https://www.greenqueen.com.hk/veganuary-celebrates-1-million-participant-as-plant-based-diet-goes-mainstream/

Else Nutrition $BABY.ca $BABYF Announces Successful Completion of Second Full-Scale Manufacturing Run and Commencement of Third Full-Scale Run in Early November $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:39 AM on Thursday, October 29th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Else has successfully completed a second commercial manufacturing run, 300% larger than the initial production run, and will commence a third manufacturing run in early November
  • This planned production run is expected to be 200% larger than the second run, and 600% larger than the inaugural one
  • Successful scale-up of production while maintaining a consistent and high-quality product is a major inflection point in the Company’s go-to market strategy
  • Else will generate additional inventory to service the Company’s expansion in the U.S. market as it rapidly expands into retail distribution, and scales its online sales

VANCOUVER, BC , Oct. 29, 2020  – ELSE NUTRITION HOLDINGS INC. (TSX-V: BABY) (OTCQX: BABYF) (FSE: 0YL) (” Else ” or the ” Company “), a commercial stage developer of plant-based alternatives to dairy-based baby nutrition, is pleased to provide an update on its North American product launch of its plant-based Toddler Nutrition product.

Else has successfully completed a second commercial manufacturing run, 300% larger than the initial production run, and will commence a third manufacturing run in early November. This planned production run is expected to be 200% larger than the second run, and 600% larger than the inaugural one. Successful scale-up of production while maintaining a consistent and high-quality product is a major inflection point in the Company’s go-to market strategy. As a result, Else will generate additional inventory to service the Company’s expansion in the U.S. market as it rapidly expands into retail distribution, and scales its online sales.

“We are encouraged by the early response to our long awaited product launch, and equally pleased to have to ramp up our inventory as we continue to see strong demand for our novel, clean-label, plant-based Toddler Nutrition product,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else.  “We are grateful for the very positive daily feedback from parents across North America , and look forward to bringing the product to store shelves soon.  Additionally, a consistent, high quality and scalable manufacturing process is a critical pillar of our business – we are pleased to have successfully completed two commercial scale runs and look forward to exponentially scaling the next one.

Else has completed the setup and order automation processes by signing up with a third-party logistics company. This provider has warehouses across the U.S. and Canada which will support Else’s E-commerce sales. Online order shipments have already commenced.

Else Nutrition’s Plant-Based Complete Nutrition for Toddlers & Babies (12+ mo.) is now available for sale on Else’s e-store at elsenutrition.com , and on Amazon.com. The Company also recently added subscription plans on its e-store.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.  

Caution Regarding Forward-Looking Statements  

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.